share_log

Investors in Stericycle (NASDAQ:SRCL) Have Unfortunately Lost 36% Over the Last Three Years

Investors in Stericycle (NASDAQ:SRCL) Have Unfortunately Lost 36% Over the Last Three Years

不幸的是,Stericycle(納斯達克股票代碼:SRCL)的投資者在過去三年中下跌了36%
Simply Wall St ·  2023/10/17 08:31

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. We regret to report that long term Stericycle, Inc. (NASDAQ:SRCL) shareholders have had that experience, with the share price dropping 36% in three years, versus a market return of about 24%.

為了證明挑選個股的努力是合理的,值得努力超越市場指數基金的回報。但幾乎可以肯定的是,有時你會買入低於市場平均回報率的股票。我們很遺憾地報告這一長期的Stercycle公司納斯達克(Sequoia Capital:SRCL)股東就有過這樣的經歷,股價在三年內下跌了36%,而市場回報率約為24%。

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

考慮到這一點,值得關注的是,該公司的潛在基本面是長期業績的驅動力,還是存在一些差異。

View our latest analysis for Stericycle

查看我們對單輪自行車的最新分析

While Stericycle made a small profit, in the last year, we think that the market is probably more focussed on the top line growth at the moment. Generally speaking, we'd consider a stock like this alongside loss-making companies, simply because the quantum of the profit is so low. It would be hard to believe in a more profitable future without growing revenues.

雖然Stercycle實現了小幅盈利,但在去年,我們認為市場目前可能更關注營收增長。一般來說,我們會把這樣的股票和虧損的公司放在一起考慮,原因很簡單,因為利潤的總量太低了。如果沒有不斷增長的收入,很難相信未來會有更有利可圖的未來。

In the last three years Stericycle saw its revenue shrink by 1.4% per year. That is not a good result. The annual decline of 11% per year in that period has clearly disappointed holders. That makes sense given the lack of either profits or revenue growth. However, in this kind of situation you can sometimes find opportunity, where sentiment is negative but the company is actually making good progress.

在過去的三年裡,Stercycle的收入以每年1.4%的速度下降。這不是一個好結果。在此期間,每年11%的跌幅顯然讓持有者感到失望。考慮到既沒有利潤也沒有收入增長,這是有道理的。然而,在這種情況下,你有時會找到機會,情緒負面,但公司實際上正在取得良好的進展。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下圖描述了收益和收入隨時間的變化(通過單擊圖像來揭示確切的價值)。

earnings-and-revenue-growth
NasdaqGS:SRCL Earnings and Revenue Growth October 17th 2023
NasdaqGS:SRCL收益和收入增長2023年10月17日

We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So it makes a lot of sense to check out what analysts think Stericycle will earn in the future (free profit forecasts).

我們喜歡的是,內部人士在過去12個月一直在買入股票。話雖如此,大多數人認為盈利和收入增長趨勢是更有意義的業務指南。因此,看看分析師認為Stericycle未來的收入(免費利潤預測)是很有意義的。

A Different Perspective

不同的視角

Stericycle shareholders are up 1.6% for the year. But that was short of the market average. But at least that's still a gain! Over five years the TSR has been a reduction of 3% per year, over five years. So this might be a sign the business has turned its fortunes around. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 2 warning signs we've spotted with Stericycle .

Stericycle股東今年以來上漲了1.6%。但這低於市場平均水準。但至少這仍然是一種收穫!五年來,TSR以每年3%的速度下降。因此,這可能是該公司扭虧為盈的跡象。雖然值得考慮市場狀況對股價可能產生的不同影響,但還有其他更重要的因素。為此,您應該意識到2個個警告標誌我們發現了一輛越野車。

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

還有很多其他公司讓內部人士買進股票。你很可能會這麼做想懷念這一切嗎?免費內部人士正在收購的成長型公司名單.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論